While there are some recent restructuring and/or downsizing news from electrical and electronic sector such as Intel Penang, Panasonic Melaka, etc., there are also good news from global pharmaceutical players to expand their investment in Malaysia.
The German-based B Braun which runs its Malaysian operations in Bayan Lepas, Penang has recently invested more than RM300 million to acquire a new plot of land to strengthen its presence with new facilities.
On the other hand, there is also news about US-based St. Jude Medical has confirmed its plan to invest in Malaysia and has already launched a $30 million site in Penang to set up Asia’s first pacemaker manufacturing facility.
Beside that, US-based Trustgen LLP and India-based Malladi Drugs & Pharmaceutical Ltd have also in October 2008 announced their decision to invest a combined $600 million investment in Malaysia to set up manufacturing facilities and their respective regional and global hubs.
All these are showing positive signs that the pharmaceutical industry in Malaysia will continue to grow despite the current worldwide economic downturn.
Meet Taipei 2024：AI 新創團隊熱潮席捲創業盛會！
1 hour ago
2 comments:
我还知道Glaxo Smithkline收购了UCB,现正在restructure，会有一批人被裁出来。
this certainly is the silver lining in the dark cloud over Penang. Must congratulate the new state gomen for this.
Hope they keep up the good work and make Penang a shining example of how the country should be run.
Cheers!
This is really running to the nth degree of technical perfection. Can't wait to try one of these Nike Lunar Racer.
Cheers!
Visit Malaysia Facts
for quick facts and interesting information about Malaysia.
Visit Penang Page for quick facts and interesting information about Penang.
Visit About ME Page for quick facts and interesting information about The Malaysian Explorer.
Post a Comment